Everest organics Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated April 10, 2026, covers the quarter ended March 31, 2026.

Regulatory Compliance Certificate

The company submitted the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This quarterly filing confirms the company's adherence to dematerialization compliance requirements for its listed securities.

Certificate Details and Verification

Venture Capital and Corporate Investments Private Limited, serving as the company's Registrar to an Issue and Share Transfer Agent, issued the compliance certificate on April 06, 2026. The certificate confirms that securities received for dematerialization have been properly processed according to regulatory standards.

Key compliance confirmations include:

• Securities received for dematerialization were mutilated and cancelled after due verification
• National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) updated as registered owners
• Processing completed within the mandated 15-day period from receipt of valid DRF and share certificates
• Details of securities furnished to relevant stock exchanges

Corporate Information

Everest Organics Limited operates as an ISO 9001:2015 and WHO GMP certified company. The company maintains its corporate office at Dwaraka Heights, Madhapur, Hitech City, Hyderabad, with its registered office and factory located at Aroor Village, Sadasivpet Mandal, Sangareddy District, Telangana.

The certificate has been made available on the company's website at everestorganicsltd.com, ensuring transparency and accessibility for stakeholders. Company Secretary and Compliance Officer Shweta Singh signed the submission, confirming the company's commitment to regulatory compliance and corporate governance standards.

Everest Organics Limited has formally disclosed to BSE the reasons behind the delayed submission of its unaudited financial results for the quarter ended December 31, 2025, citing extended board deliberations and additional information requirements that prevented timely compliance with regulatory deadlines.

Regulatory Communication Details

The company submitted its explanation to BSE on March 06, 2026, in response to the exchange's email dated March 05, 2026, regarding non-compliance with Regulation 33(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication addressed the company's failure to submit results within the prescribed 45-day period and the subsequent delay in providing explanatory disclosures.

Board Meeting Timeline and Challenges

The company provided specific details about the circumstances that led to the delay:

The extended duration of the board meeting, involving detailed discussions that continued past midnight, contributed to the company's inability to meet the regulatory timeline. The board's requirement for additional information before finalizing the results further complicated the submission process.

Compliance Actions and Acknowledgments

Everest Organics confirmed that despite the delay in the initial submission timeline, the company uploaded both the Board Meeting outcome and unaudited financial results on the BSE Listing Portal immediately upon the meeting's conclusion on February 15, 2026. The submissions were made in both PDF and XBRL formats as required by regulations.

The company acknowledged its oversight in not submitting the detailed reasons for delay within one working day as prescribed by regulations. Management noted that February 15, 2026, being the day of results submission, was not a working day for the Stock Exchange, which contributed to the procedural complications.

Trading Window and Insider Trading Compliance

In accordance with SEBI (Prohibition of Insider Trading) Regulations, the company maintained proper trading window protocols. The trading window remained closed and was reopened after 48 hours from the declaration of the unaudited financial results, ensuring compliance with insider trading prevention measures.

Future Compliance Assurance

Everest Organics has provided assurance to BSE regarding improved compliance measures going forward. The company stated it will take necessary care to ensure timely submission of all required disclosures in future and confirmed that such oversights will not occur again. The management has requested BSE to take the explanation on record and condone the delay in submission of the required disclosure.